EXAS : Summary for Exact Sciences Corporation - Yahoo Finance

U.S. Markets closed

Exact Sciences Corporation (EXAS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
20.49+0.09 (+0.44%)
At close: 4:00PM EDT

20.49 0.00 (0.00%)
After hours: 5:05PM EDT

People also watch
EXELACADARRYSRPTCLVS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close20.40
Open20.50
Bid18.12 x 100
Ask25.12 x 500
Day's Range20.01 - 20.99
52 Week Range5.36 - 24.50
Volume2,485,317
Avg. Volume2,775,466
Market Cap2.27B
Beta1.14
PE Ratio (TTM)-12.54
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Billionaires' Best Healthcare Stock Picks of 2017 (So Far)
    Motley Fool2 days ago

    Billionaires' Best Healthcare Stock Picks of 2017 (So Far)

    Why billionaire investors are loving Immunomedics, Achaogen, AveXis, Exact Sciences, and Clovis Oncology this year.

  • PR Newswire6 days ago

    Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees

    MADISON, Wis., March 17, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 85,421 shares of common stock to 77 recently hired non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4).  The Company is making this announcement as required by NASDAQ rules.

  • Motley Fool10 days ago

    Why Exact Sciences Shares Are Already Up 65% in 2017

    Growing demand for its new colon cancer screening test is fueling investors' excitement.